Long-term treatment with anti-CD20 monoclonal antibodies is untenable because of risk: Commentary.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 8, p. 1177, doi. 10.1177/13524585221101138
- By:
- Publication type:
- Article
Works matching IS 13524585 AND DT 2022 AND VI 28 AND IP 8
Results: 18
1
2
Long-term treatment with anti-CD20 monoclonal antibodies is untenable because of risk: No.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 8, p. 1175, doi. 10.1177/13524585221091404
- By:
- Publication type:
- Article
3
Long-term treatment with anti-CD20 monoclonal antibodies is untenable because of risk: YES.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 8, p. 1173, doi. 10.1177/13524585221088734
- By:
- Publication type:
- Article
4
Diagnosis concealment is associated with psychosocial outcomes in persons with multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 8, p. 1311, doi. 10.1177/13524585211070496
- By:
- Publication type:
- Article
5
Impact of clinical outcomes and imaging measures on health-related quality of life in secondary progressive MS.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 8, p. 1286, doi. 10.1177/13524585211063623
- By:
- Publication type:
- Article
6
Body mass index as a predictor of MS activity and progression among participants in BENEFIT.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 8, p. 1277, doi. 10.1177/13524585211061861
- By:
- Publication type:
- Article
7
The health-related quality of life of children with multiple sclerosis is mediated by the health-related quality of life of their parents.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 8, p. 1299, doi. 10.1177/13524585211061521
- By:
- Publication type:
- Article
8
Epidemiological investigation of multiple sclerosis and related medical utilisation in Taiwan.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 8, p. 1198, doi. 10.1177/13524585211061341
- By:
- Publication type:
- Article
9
Assessment of automatic decision-support systems for detecting active T2 lesions in multiple sclerosis patients.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 8, p. 1209, doi. 10.1177/13524585211061339
- By:
- Publication type:
- Article
10
Reduced expression of mitochondrial fumarate hydratase in progressive multiple sclerosis contributes to impaired in vitro mesenchymal stromal cell-mediated neuroprotection.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 8, p. 1179, doi. 10.1177/13524585211060686
- By:
- Publication type:
- Article
11
Computational basis of decision-making impairment in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 8, p. 1267, doi. 10.1177/13524585211059308
- By:
- Publication type:
- Article
12
Impact of comorbid post traumatic stress disorder on multiple sclerosis in military veterans: A population-based cohort study.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 8, p. 1257, doi. 10.1177/13524585211058361
- By:
- Publication type:
- Article
13
Pregnancy in women with MS: Impact on long-term disability accrual in a nationwide Danish Cohort.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 8, p. 1239, doi. 10.1177/13524585211057767
- By:
- Publication type:
- Article
14
Effect of ofatumumab versus placebo in relapsing multiple sclerosis patients from Japan and Russia: Phase 2 APOLITOS study.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 8, p. 1229, doi. 10.1177/13524585211055934
- By:
- Publication type:
- Article
15
A higher burden of multiple sclerosis genetic risk confers an earlier onset.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 8, p. 1189, doi. 10.1177/13524585211053155
- By:
- Publication type:
- Article
16
Durability of no evidence of disease activity-3 (NEDA-3) in patients receiving cladribine tablets: The CLARITY extension study.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 8, p. 1219, doi. 10.1177/13524585211049392
- By:
- Publication type:
- Article
17
Multiple sclerosis diagnosis: Knowledge gaps and opportunities for educational intervention in neurologists in the United States.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 8, p. 1248, doi. 10.1177/13524585211048401
- By:
- Publication type:
- Article
18
Exercise and the brain in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 8, p. 1167, doi. 10.1177/1352458520969099
- By:
- Publication type:
- Article